Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Product R: ADVR said it would start an Israeli Phase I dose-escalation trial of Product R to treat cachexia in patients with solid tumors

Advanced Viral Research Corp. (ADVR), Yonkers,

Read the full 61 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE